Correlation Between Aerovate Therapeutics and Umbra Applied

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Umbra Applied at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Umbra Applied into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Umbra Applied Technologies, you can compare the effects of market volatilities on Aerovate Therapeutics and Umbra Applied and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Umbra Applied. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Umbra Applied.

Diversification Opportunities for Aerovate Therapeutics and Umbra Applied

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Aerovate and Umbra is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Umbra Applied Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Umbra Applied Techno and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Umbra Applied. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Umbra Applied Techno has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Umbra Applied go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Umbra Applied

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Umbra Applied. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 4.07 times less risky than Umbra Applied. The stock trades about -0.08 of its potential returns per unit of risk. The Umbra Applied Technologies is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest  0.32  in Umbra Applied Technologies on September 13, 2024 and sell it today you would earn a total of  0.17  from holding Umbra Applied Technologies or generate 53.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.45%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Umbra Applied Technologies

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Umbra Applied Techno 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Umbra Applied Technologies are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Umbra Applied reported solid returns over the last few months and may actually be approaching a breakup point.

Aerovate Therapeutics and Umbra Applied Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Umbra Applied

The main advantage of trading using opposite Aerovate Therapeutics and Umbra Applied positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Umbra Applied can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Umbra Applied will offset losses from the drop in Umbra Applied's long position.
The idea behind Aerovate Therapeutics and Umbra Applied Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Transaction History
View history of all your transactions and understand their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume